US Stock MarketDetailed Quotes
PSTV Plus Therapeutics
- 1.3601
- +0.0101+0.75%
Close Nov 4 16:00 ET
- 1.3000
- -0.0601-4.42%
Post 20:01 ET
8.02MMarket Cap-440P/E (TTM)
1.3800High1.3300Low31.41KVolume1.3800Open1.3500Pre Close42.59KTurnover0.55%Turnover RatioLossP/E (Static)5.90MShares2.780052wk High-1.05P/B7.82MFloat Cap1.145052wk Low--Dividend TTM5.75MShs Float7507.4985Historical High--Div YieldTTM3.70%Amplitude0.9690Historical Low1.3550Avg Price1Lot Size
Plus Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 58.60%-1.15M | 22.10%-4.51M | 0.93%-12.85M | 15.80%-1.88M | 43.18%-2.4M | -5.23%-2.78M | -49.46%-5.79M | -26.19%-12.97M | 14.86%-2.23M | -87.56%-4.22M |
| Net income from continuing operations | -98.38%-2.94M | 32.13%-3.26M | 34.32%-13.32M | 32.66%-3.81M | 38.32%-3.22M | 71.94%-1.48M | -16.74%-4.81M | -51.32%-20.28M | -36.17%-5.66M | -40.15%-5.22M |
| Operating gains losses | ---- | ---- | --2K | --0 | --0 | --0 | --2K | ---- | ---- | ---- |
| Depreciation and amortization | 7.45%202K | -0.53%186K | 1.45%628K | -30.11%65K | -16.07%188K | 44.62%188K | 8.72%187K | 56.71%619K | -27.91%93K | 157.47%224K |
| Other non cash items | 6,596.23%3.55M | -75.76%16K | -31.70%265K | -62.03%30K | 26.09%116K | -48.54%53K | -42.11%66K | -50.89%388K | -77.99%79K | -38.67%92K |
| Change In working capital | 255.40%2.61M | -15.76%-1.6M | -119.94%-1.12M | -47.95%1.58M | -37.73%368K | -176.09%-1.68M | -511.95%-1.38M | 352.10%5.6M | 274.75%3.03M | -42.29%591K |
| -Change in receivables | ---- | ---- | ---- | ---- | -1,208.22%-809K | ---- | ---- | ---- | ---- | --73K |
| -Change in payables and accrued expense | 706.00%403K | 98.82%-43K | -156.99%-3.68M | -91.46%384K | -210.28%-472K | -97.70%50K | -459.85%-3.64M | 272.09%6.45M | 241.72%4.5M | -57.24%428K |
| -Change in other current assets | 114.44%185K | -94.63%150K | 201.18%2.4M | 73.66%-793K | 1,335.90%1.68M | -2,040.91%-1.28M | 508.06%2.79M | -377.62%-2.37M | -492.72%-3.01M | 408.70%117K |
| -Change in other current liabilities | -18.52%-32K | -6.90%-31K | 9.30%-117K | -7.14%-30K | -14.81%-31K | 30.77%-27K | 17.14%-29K | ---129K | ---28K | ---27K |
| -Change in other working capital | 280.30%2.05M | -231.42%-1.68M | -82.90%281K | --1.92M | --0 | ---1.14M | ---506K | --1.64M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 58.60%-1.15M | 22.10%-4.51M | 0.93%-12.85M | 15.80%-1.88M | 43.18%-2.4M | -5.23%-2.78M | -49.46%-5.79M | -26.19%-12.97M | 14.86%-2.23M | -87.56%-4.22M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -34,463.64%-3.8M | -275.26%-364K | 78.92%-160K | -281.82%-42K | 69.70%-10K | 92.03%-11K | 83.19%-97K | -825.61%-759K | -650.00%-11K | -725.00%-33K |
| Net PPE purchase and sale | -636.36%-81K | 58.76%-40K | 68.57%-160K | 67.19%-42K | 69.70%-10K | 92.03%-11K | 53.81%-97K | -520.73%-509K | -6,500.00%-128K | -725.00%-33K |
| Net intangibles purchase and sale | ---- | ---- | --0 | --0 | --0 | ---- | ---- | ---250K | --117K | --0 |
| Net investment purchase and sale | ---3.18M | ---324K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -34,463.64%-3.8M | -275.26%-364K | 78.92%-160K | -281.82%-42K | 69.70%-10K | 92.03%-11K | 83.19%-97K | -825.61%-759K | -650.00%-11K | -725.00%-33K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 624.56%6.96M | -257.40%-776K | -74.39%3.45M | -634.34%-529K | -60.81%2.52M | 359.03%961K | -93.24%493K | -34.12%13.45M | 138.37%99K | 0.89%6.43M |
| Net issuance payments of debt | 24.88%-302K | 0.00%-402K | 0.00%-1.61M | 0.00%-402K | 0.00%-402K | 0.00%-402K | 0.00%-402K | -482.61%-1.61M | -50.00%-402K | ---402K |
| Net common stock issuance | 433.02%7.27M | -141.79%-374K | -65.89%5.4M | -82.65%221K | -57.24%2.92M | 4,296.77%1.36M | -88.37%895K | -15.22%15.83M | 12,640.00%1.27M | 7.20%6.83M |
| Net other financing activities | ---- | ---- | 54.98%-348K | ---- | ---- | ---- | ---- | ---773K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 624.56%6.96M | -257.40%-776K | -74.39%3.45M | -634.34%-529K | -60.81%2.52M | 359.03%961K | -93.24%493K | -34.12%13.45M | 138.37%99K | 0.89%6.43M |
| Net cash flow | ||||||||||
| Beginning cash position | -77.20%2.9M | -52.79%8.55M | -1.52%18.12M | -45.69%11.01M | -39.77%10.9M | -40.10%12.72M | -1.52%18.12M | 120.46%18.4M | -4.77%20.27M | 5.41%18.09M |
| Current changes in cash | 210.01%2.01M | -4.74%-5.65M | -3,316.43%-9.57M | -14.26%-2.45M | -94.90%111K | 41.95%-1.83M | -290.10%-5.4M | -102.78%-280K | 25.49%-2.15M | -47.17%2.18M |
| End cash Position | -54.92%4.91M | -77.20%2.9M | -52.79%8.55M | -52.79%8.55M | -45.69%11.01M | -39.77%10.9M | -40.10%12.72M | -1.52%18.12M | -1.52%18.12M | -4.77%20.27M |
| Free cash flow | 36.32%-1.78M | 22.70%-4.55M | 5.24%-13.01M | 14.34%-1.92M | 43.38%-2.41M | -0.40%-2.79M | -32.27%-5.89M | -31.72%-13.73M | 14.77%-2.25M | -84.60%-4.26M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data